{"transactions":[{"id":921308,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T16:07:18.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":38190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027."}],"balance_after":38190,"derivative":{"exercise_price":10.85,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":38190},"source":{"system":"sec-edgar","filing":"0000905148-26-000480","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000090514826000480/form4.xml","form_type":"4"}},{"id":1287078,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-03T18:22:09.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":305500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on January 31, 2026. The remainder vests in 36 monthly installments beginning on February 28, 2026."}],"balance_after":305500,"derivative":{"exercise_price":0.8048,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":305500},"source":{"system":"sec-edgar","filing":"0000905148-25-000332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000090514825000332/form4.xml","form_type":"4"}},{"id":1552883,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-04-02T16:44:34.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":244400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one year anniversary of the grant, March 29, 2025."}],"balance_after":244400,"derivative":{"exercise_price":2.23,"expiration_date":"2034-03-28","underlying":"Common Stock","underlying_shares":244400},"source":{"system":"sec-edgar","filing":"0000905148-24-001054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000090514824001054/form4.xml","form_type":"4"}},{"id":1663728,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-01T16:45:30.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":305500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025."}],"balance_after":305500,"derivative":{"exercise_price":1.22,"expiration_date":"2034-01-30","underlying":"Common Stock","underlying_shares":305500},"source":{"system":"sec-edgar","filing":"0000905148-24-000395","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000090514824000395/form4.xml","form_type":"4"}},{"id":1844952,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T16:45:50.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.26,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-23-018280","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000143774923018280/rdgdoc.xml","form_type":"4"}},{"id":1983165,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-01T18:01:49.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":309000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024."}],"balance_after":309000,"derivative":{"exercise_price":1.55,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":309000},"source":{"system":"sec-edgar","filing":"0001140361-23-009489","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000114036123009489/form4.xml","form_type":"4"}},{"id":2221849,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T19:02:42.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on the date of the Company's 2023 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.82,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001583648-22-000049","document":"wf-form4_165611174598543.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000158364822000049/wf-form4_165611174598543.xml","form_type":"4"}},{"id":2415971,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-02T16:18:12.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":262400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023."}],"balance_after":262400,"derivative":{"exercise_price":5.57,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":262400},"source":{"system":"sec-edgar","filing":"0000905148-22-000160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000090514822000160/form4.xml","form_type":"4"}},{"id":2651395,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-29T17:33:57.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on the date of the Company's 2022 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":4,"expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-21-004562","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218021004562/primarydocument.xml","form_type":"4"}},{"id":2785687,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-16T16:48:28.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on March 15, 2022. The remainder vests in 36 monthly installments beginning on April 15, 2022."}],"balance_after":300000,"derivative":{"exercise_price":12.59,"expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001123292-21-000496","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000112329221000496/edgar.xml","form_type":"4"}},{"id":3099613,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-25T16:45:55.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on June 23, 2021, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.27,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-20-004691","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218020004691/primarydocument.xml","form_type":"4"}},{"id":3231188,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-03T16:35:17.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the option vests on February 28, 2021. The remainder vests in 36 monthly installments beginning on March 28, 2021."}],"balance_after":225000,"derivative":{"exercise_price":41.76,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001123292-20-000457","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000112329220000457/edgar.xml","form_type":"4"}},{"id":3299932,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-28T16:18:47.000Z","date":"2020-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest as to 100% of the underlying shares on January 25, 2021, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.23,"expiration_date":"2030-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-20-000619","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218020000619/primarydocument.xml","form_type":"4"}},{"id":3299931,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-28T16:18:47.000Z","date":"2020-01-25","kind":"grant","acquired":true,"shares":5431,"price":2.107,"value":11443.117,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $11,445.56 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":5431,"derivative":{"exercise_price":3.23,"exercise_date":"2020-01-25","expiration_date":"2030-01-25","underlying":"Common Stock","underlying_shares":5431},"source":{"system":"sec-edgar","filing":"0001562180-20-000619","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218020000619/primarydocument.xml","form_type":"4"}},{"id":3387058,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-10-28T16:38:27.000Z","date":"2019-10-25","kind":"grant","acquired":true,"shares":5165,"price":2.118,"value":10939.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":5165,"derivative":{"exercise_price":3.24,"exercise_date":"2019-10-25","expiration_date":"2029-10-25","underlying":"Common Stock","underlying_shares":5165},"source":{"system":"sec-edgar","filing":"0001562180-19-005263","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218019005263/primarydocument.xml","form_type":"4"}},{"id":3455121,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-26T16:13:47.000Z","date":"2019-07-25","kind":"grant","acquired":true,"shares":3789,"price":2.89,"value":10950.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":3789,"derivative":{"exercise_price":4.4,"exercise_date":"2019-07-25","expiration_date":"2029-07-25","underlying":"Common Stock","underlying_shares":3789},"source":{"system":"sec-edgar","filing":"0001562180-19-004075","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218019004075/primarydocument.xml","form_type":"4"}},{"id":3545320,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-30T17:36:54.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":5640,"price":1.94,"value":10941.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears, pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":5640,"derivative":{"exercise_price":2.94,"exercise_date":"2019-04-25","expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":5640},"source":{"system":"sec-edgar","filing":"0001562180-19-002447","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218019002447/primarydocument.xml","form_type":"4"}},{"id":3683607,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T17:45:57.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest as to 100% of the underlying shares on January 25, 2020, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.74,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-19-000579","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218019000579/primarydocument.xml","form_type":"4"}},{"id":3683606,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T17:45:57.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":6096,"price":1.79,"value":10911.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears, pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":6096,"derivative":{"exercise_price":2.74,"exercise_date":"2019-01-25","expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":6096},"source":{"system":"sec-edgar","filing":"0001562180-19-000579","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218019000579/primarydocument.xml","form_type":"4"}},{"id":3781172,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-29T17:11:26.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":3829,"price":2.86,"value":10950.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":3829,"derivative":{"exercise_price":4.36,"exercise_date":"2018-10-25","expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":3829},"source":{"system":"sec-edgar","filing":"0001562180-18-004310","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218018004310/primarydocument.xml","form_type":"4"}},{"id":3860713,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T17:10:50.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":2837,"price":3.86,"value":10950.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":2837,"derivative":{"exercise_price":5.92,"exercise_date":"2018-07-25","expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":2837},"source":{"system":"sec-edgar","filing":"0001562180-18-003419","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218018003419/primarydocument.xml","form_type":"4"}},{"id":3955985,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-26T18:14:04.000Z","date":"2018-04-25","kind":"grant","acquired":true,"shares":2665,"price":4.1,"value":10926.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":2665,"derivative":{"exercise_price":6.43,"exercise_date":"2018-04-25","expiration_date":"2028-04-25","underlying":"Common Stock","underlying_shares":2665},"source":{"system":"sec-edgar","filing":"0001562180-18-002005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218018002005/primarydocument.xml","form_type":"4"}},{"id":4086265,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T16:39:28.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30 and December 31, 2018."}],"balance_after":20000,"derivative":{"exercise_price":7.72,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-18-000481","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218018000481/primarydocument.xml","form_type":"4"}},{"id":4086264,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T16:39:28.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":2243,"price":5.09,"value":11416.87,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $11,406.25 in cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":2243,"derivative":{"exercise_price":7.72,"exercise_date":"2018-01-25","expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":2243},"source":{"system":"sec-edgar","filing":"0001562180-18-000481","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218018000481/primarydocument.xml","form_type":"4"}},{"id":4179338,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rights to buy)","published_at":"2017-10-27T16:26:21.000Z","date":"2017-10-25","kind":"grant","acquired":true,"shares":4006,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4006,"derivative":{"exercise_price":4.68,"exercise_date":"2017-10-25","expiration_date":"2027-10-25","underlying":"Common Stock","underlying_shares":4006},"source":{"system":"sec-edgar","filing":"0001562180-17-003340","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000156218017003340/primarydocument.xml","form_type":"4"}},{"id":4249919,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T20:23:00.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":3288,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3288,"derivative":{"exercise_price":5.64,"exercise_date":"2017-07-25","expiration_date":"2027-07-25","underlying":"Common Stock","underlying_shares":3288},"source":{"system":"sec-edgar","filing":"0000899243-17-019252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000089924317019252/doc4.xml","form_type":"4"}},{"id":4276501,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-06-20T16:34:25.000Z","date":"2017-06-16","kind":"exercise","acquired":false,"shares":2250,"price":3.8,"value":8550.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, the vesting date of unvested stock options accelerated to vest and become exercisable as of the closing of the merger."}],"balance_after":0,"derivative":{"exercise_price":3.8,"exercise_date":"2017-06-16","expiration_date":"2017-06-16","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001123292-17-001162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001162/edgar.xml","form_type":"4"}},{"id":4276500,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:34:25.000Z","date":"2017-06-16","kind":"disposition_to_issuer","acquired":false,"shares":1061,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"2.\tThe shares of Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated January 24, 2017, among the Issuer, Intrexon Corporation (\"Intrexon\") and Intrexon GV Holding, Inc. (the \"Merger Agreement\") in exchange for (i) 315 shares of Intrexon common stock having a market value of $7,188 as of the close of trading on the date immediately prior to the effective date of the merger, and cash in lieu of fractional shares of Intrexon common stock, plus (ii) one contingent payment right (the \"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"[footnote 2 continued] Each contingent payment right entitles the holder thereof to an amount equal to half of certain payments actually received by the registrant or its successor or any of their affiliates from or on behalf of Novartis Institutes for BioMedical Research, Inc. (\"Novartis\") under the Research Collaboration and License Agreement, dated January 13, 2010, as amended, between the registrant and Novartis, on account of milestone payments or royalties due in relation to the period ending June 16, 2019, divided by the number of shares of the regisrant's common stock having rights to the Merger Consideration, subject to any withholding of taxes required by applicable law."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of pursuant to the Merger Agreement in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001123292-17-001162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001162/edgar.xml","form_type":"4"}},{"id":4276499,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:34:25.000Z","date":"2017-06-16","kind":"tax_withholding","acquired":false,"shares":1189,"price":7.19,"value":8548.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Withholding of Common Stock to pay exercise price."}],"balance_after":1061,"source":{"system":"sec-edgar","filing":"0001123292-17-001162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001162/edgar.xml","form_type":"4"}},{"id":4276498,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:34:25.000Z","date":"2017-06-16","kind":"exercise","acquired":true,"shares":2250,"price":3.8,"value":8550.0,"ownership":{"direct":true},"balance_after":2250,"source":{"system":"sec-edgar","filing":"0001123292-17-001162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/934473/000112329217001162/edgar.xml","form_type":"4"}},{"id":4343384,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-04-27T18:06:50.000Z","date":"2017-04-25","kind":"grant","acquired":true,"shares":7821,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7821,"derivative":{"exercise_price":2.32,"exercise_date":"2017-04-25","expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":7821},"source":{"system":"sec-edgar","filing":"0000899243-17-011040","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000089924317011040/doc4.xml","form_type":"4"}},{"id":4477067,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-30T19:02:42.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017."}],"balance_after":20000,"derivative":{"exercise_price":2.01,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-002203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000089924317002203/doc4.xml","form_type":"4"}},{"id":4477066,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-30T19:02:42.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":9687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":9687,"derivative":{"exercise_price":2.01,"exercise_date":"2017-01-25","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":9687},"source":{"system":"sec-edgar","filing":"0000899243-17-002203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000089924317002203/doc4.xml","form_type":"4"}},{"id":4573415,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-27T19:27:15.000Z","date":"2016-10-25","kind":"grant","acquired":true,"shares":9656,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9656,"derivative":{"exercise_price":1.64,"exercise_date":"2016-10-25","expiration_date":"2026-10-25","underlying":"Common Stock","underlying_shares":9656},"source":{"system":"sec-edgar","filing":"0000899243-16-032393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366265/000089924316032393/doc4.xml","form_type":"4"}},{"id":4575768,"issuer":{"id":175088,"kind":"organization","name":"GENVEC INC","symbol":"GNVC"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2016-10-24T16:48:12.000Z","date":"2016-10-20","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22500,"derivative":{"exercise_price":0.38,"exercise_date":"2017-10-20","expiration_date":"2026-10-20","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001140361-16-083405","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/934473/000114036116083405/doc1.xml","form_type":"4"}},{"id":4587795,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":67925,"kind":"person","name":"Richman Michael","position":1,"cik":"0001366265","reported_name":"Richman Michael","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-10-04T08:01:43.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":6455,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25884,"source":{"system":"sec-edgar","filing":"0001354488-16-008339","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000135448816008339/issuerdirect_section16.xml","form_type":"4"}}]}